HOME >> BIOLOGY >> NEWS
Genomatix partners with Research Instruments Pte Ltd for Singapore, Malaysia and Thailand markets

Genomatix Software GmbH of Munich (Germany) said today that Singapore-based Research Instruments Pte Ltd (RI) will distribute the Genomatix line of products in Singapore, Malaysia and Thailand.

A first result of that partnership is a three year deal with the Clinical Research Department of the Singapore General Hospital (SGH). SGH will apply the Genomatix Chip Analysis pipeline to their Affymetrix based expression studies.

"I am very excited about this partnership with RI", says Klaus May, Director of Sales & Marketing at Genomatix. "Beyond other technologies, RI is one of the strongest providers of Affymetrix chips and services in this area. With our ChipInspector and GenomatixSuitePE products, now RI is a one-stop-shop for providing latest science, technology and services in South East Asia.", he continues.


'"/>

Contact: Klaus May
may@genomatix.de
49-895-997-660
Genomatix Software GmbH
6-Mar-2006


Page: 1

Related biology news :

1. Genomatix expands operations in North America
2. Application of Genomatix in silico methods reveals novel cancer associated genes
3. Genomatix and Molecular Connections form strategic partnership
4. Genomatix wins BioChance grant worth $1.6 million
5. Genomatix appoints distributor for the growing Chinese market
6. MatBase -- A new transcription factor knowledge base released by Genomatix
7. The Center of Nutrigenomics of the TU Munich licences Genomatix Microarray Analysis Pipeline
8. Bayer HealthCare licenses Genomatix for microarray analysis
9. Genomatix technology facilitates de novo identification of new renal disease associated genes
10. German Microarray Excellence Center integrates Genomatix Chip Analysis Pipeline
11. Genomatix improves its coverage of Affymetrix new exon arrays

Post Your Comments:
(Date:2/5/2015)... Jan. 28, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... RedChip Global Online CEO Conference on January 29 th ... Gino Pereira , CEO of NXT-ID will present and ... the Wocket smart wallet and its full suite of ...
(Date:2/5/2015)... 3, 2015 Despite a lack of ... such as consumer electronics, automotive, storage and telecommunication ... technology (SMT) screen printers. Innovations in electronics and ... push the adoption curve up. Meanwhile, sale volumes ... glue dispensers are indispensable in the production of ...
(Date:1/22/2015)... FindBiometrics, the leading source of biometrics industry news, interviews and ... "When we launched FindBiometrics 12 years ago the ... founder and CEO of FindBiometrics. "Now it,s maturing very quickly. ... players on a very broad scale.  We are known for ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2
(Date:2/27/2015)... , Feb. 27, 2015 Research and Markets ... "Global Market Report of Trypsin" report to their ... (CAS 9002-07-7) aims at providing comprehensive data on Trypsin globally ... , North America , ... pays close attention to Trypsin This report focuses ...
(Date:2/27/2015)... Australia , Feb. 27, 2015 Bionomics ... from the DisrupTOR-1 trial of BNC105 in patients with ... in Orlando, Florida . The data ... of the City of Hope Comprehensive Cancer Center in ... The new data identifies Ferritin and ...
(Date:2/27/2015)... 2015 Cytokinetics, Incorporated (Nasdaq: CYTK) announced ... with patients and health care advocates in the United ... Day®. Rare Disease Day is dedicated to elevating ... the special challenges faced by patients with rare diseases ... proud to stand alongside patients and caregivers representing the ...
(Date:2/26/2015)... NEW YORK , Feb. 26, 2015 ... commenced Factual Stock Report coverage on MabVax Therapeutics ... Inc. (MBVX) is a clinical stage biotechnology company focused ... address unmet medical needs in the treatment of cancer. ... products based on the protective immune responses generated by ...
Breaking Biology Technology:Global Market Report of Trypsin 2014-2018 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5
Cached News: